Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesCoagulation defects, purpura and other hemorrhagic conditionsICD-10-CM d68-other-coagulation-defects
    Ask Trek AI about this page

    ICD-10-CM Code For Other Coagulation Defects: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group D68 includes a range of inherited and acquired coagulation disorders, such as deficiencies of clotting factors, anticoagulant abnormalities, and other hemorrhagic conditions that impair normal hemostasis. These ICD-10-CM diagnosis codes are used to document clinical presentations involving bleeding tendencies, thrombotic events, or coagulopathy secondary to other diseases, capturing disease severity, organ involvement, or clinical complexity relevant to this group. Accurate coding within the ICD-10-CM D68 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Other Coagulation Defects: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM D68: Other Coagulation Defects Overview

    The other coagulation defects group includes inherited and acquired disorders of blood coagulation that lead to bleeding or thrombosis and other hemorrhagic conditions. These diagnoses primarily affect the hematologic system and hemostasis mechanisms. Accurate coding matters for appropriate clinical documentation and reimbursement because specificity influences claim adjudication and care tracking.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use codes from this group when a patient has documented abnormal coagulation function due to a specific factor deficiency, antibody-mediated coagulopathy, or other hemorrhagic condition. Select the most specific code that reflects the identified disorder, associated complications, and any underlying cause when documented in the medical record.

    ICD-10-CM Codes

    25 rows

    ICD-10-CM CodeDescription
    D68.00Von Willebrand disease, unspecified
    D68.01Von Willebrand disease, type 1
    D68.020Von Willebrand disease, type 2A
    D68.021Von Willebrand disease, type 2B
    D68.022Von Willebrand disease, type 2M
    D68.023Von Willebrand disease, type 2N
    D68.029Von Willebrand disease, type 2, unspecified
    D68.03Von Willebrand disease, type 3
    D68.04Acquired von Willebrand disease
    D68.09Other von Willebrand disease
    D68.1Hereditary factor XI deficiency
    D68.2Hereditary deficiency of other clotting factors
    D68.311Acquired hemophilia
    D68.312Antiphospholipid antibody with hemorrhagic disorder
    D68.318Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
    D68.32Hemorrhagic disorder due to extrinsic circulating anticoagulants
    D68.4Acquired coagulation factor deficiency
    D68.51Activated protein C resistance
    D68.52Prothrombin gene mutation
    D68.59Other primary thrombophilia

    Showing 1–20 of 25

    DRG Codes

    4 rows

    DRG CodeDescription
    813Coagulation Disorders
    814Reticuloendothelial and Immunity Disorders with MCC
    815Reticuloendothelial and Immunity Disorders with CC
    816Reticuloendothelial and Immunity Disorders without CC/MCC

    Typical Clinical Scenarios

    • A middle-aged woman presents to the emergency department with sudden onset of large-volume hematuria and spontaneous skin ecchymoses after several days of antibiotic therapy; laboratory testing shows markedly prolonged bleeding times and a new severe thrombocytopenia consistent with immune-mediated platelet destruction. A diagnosis from this coagulation defects group is assigned because the presentation represents an acute hemorrhagic disorder requiring identification of the specific coagulation or platelet abnormality. Typical codes: D68.3, D68.32
    • A 45-year-old man with a long history of recurrent deep bruising and mucosal bleeding since childhood is seen in hematology for evaluation of a chronic bleeding diathesis; platelet function studies reveal an inherited platelet function disorder with abnormal aggregation but stable platelet counts. A code from this group is assigned to document the chronic platelet function defect as the cause of bleeding and for ongoing management and counseling. Typical codes: D68.4, D68.9
    • An elderly patient is admitted for hip fracture repair and develops postoperative diffuse oozing and prolonged coagulation studies while on therapeutic anticoagulation for atrial fibrillation; clinicians must identify the specific coagulation defect contributing to surgical bleeding to guide reversal and perioperative care. A diagnosis from this group is used to capture the acquired coagulation defect complicating the surgical course. Typical codes: D68.20, D68.29

    Related Codes

    D65-DISSEMINATED-INTRAVASCULAR-COAGULATION

    ICD-10-CM Code For Disseminated Intravascular Coagulation Defibrination Syndrome: Group Overview

    D66-HEREDITARY-FACTOR-VIII-DEFICIENCY

    ICD-10-CM Code For Hereditary Factor VIII Deficiency: Group Overview

    D67-HEREDITARY-FACTOR-IX-DEFICIENCY

    ICD-10-CM Code For Hereditary Factor IX Deficiency: Group Overview

    D69-PURPURA-AND-HEMORRHAGIC-CONDITIONS

    ICD-10-CM Code For Purpura And Other Hemorrhagic Conditions: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.